Researchers Discover Urine-Based Test to Detect Head and Neck Cancer
Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Category: Cervical (HPV)
Cervical (HPV)
Latest
Cervical (HPV)
Latest
Physically Disabled Women Less Likely to be Screened for Cervical Cancer
Physically disabled women may encounter barriers to reproductive health care and a lack of timely access to cervical cancer screening.
Cervical (HPV)
Latest
Over Half of Saudi Arabian Women Haven’t Screened for Cervical Cancer
Only 19% of Saudi Arabian women are diagnosed with stage I cervical cancer where survival rates are highest, according to a new study.
Virax Biolabs Introduces HPV Test Kit
Virax Biolabs announced the distribution of HPV test kits with shipments anticipated in the first quarter of 2023.
Read More
Why the Triage Approach Will Improve Cervical Cancer Screening and Diagnosis
The triage approach offers women and labs a more efficient and effective way to diagnose and manage cervical cancer earlier.
Read More
Are Older Women Being Over-Screened for Cervical Cancer?
A new study suggests that women over the age of 65 may be undergoing unnecessary cervical cancer screenings.
Read More
The Future of Cervical Cancer Screening is Here
As women catch up on missed cervical cancer screenings, more tools are needed that will be able to identify cancer-causing HPV genotypes.
Read More
ISH Technology Allows for Detection of HPV
Enzo Biochem, Inc. has launched the AMPIVIEW line, an RNA gene expression platform powered by Enzo’s LoopRNA ISH technology.
Read More
Total Testing Solutions & OmniPathology Offer Oral HPV Testing in LA
Total Testing Solutions announced a partnership with OmniPathology to offer oral HPV testing in the Los Angeles area.
Read More
Women Who Test Negative for HPV Can Safely Screen Every Five Years, Study Shows
A new study supports the extension of cervical cancer screening intervals to five years for those with a negative screen result.
Read More
Cervical Cancer Screening Rates Low Among Sexual Minority Individuals
A recent analysis found sexual minority individuals less likely to undergo cervical cancer screening than their heterosexual counterparts.
Read More
Half of Eligible Women Prefer Self-Sampling for Cervical Screening
A new study found in a questionnaire that 51.4% of women preferred self-sampling for HPV-based cervical cancer screening.
Read More
Seegene’s New PCR Assay Offers Three-Target Cycle Threshold Value Tech
Molecular diagnostics company Seegene today announced the development of a commercialized PCR assay that applies “3 Ct” technology.
Read More
Same-Day Cervical Cancer Screening & Prevention Tool Streamlines Treatment
The cervical cancer screening tool enables physicians to detect and remove pre-cancerous cells from the cervix during the same appointment.
Read More
Why Cervical Cancer Screening Rates are Declining
Rates of cervical cancer screenings have dropped in the U.S., with rates lowest among Asian and Hispanic women.
Read More
Test Shows Benefit for Detecting Women at Risk for Cervical Cancer
Results from the IMPACT trial demonstrate clear patient benefit in using Roche’s CINtec PLUS Cytology dual-stain biomarker technology.
Read More
Some Women Receive HPV and Cervical Cancer Screening too often
Researchers have found that many women are screened for cervical cancer too often, while others are not getting tested often enough.
Read More
Circulating Tumor DNA Leads to Detection of HPV
Researchers have made new findings, which may improve detection of the human papillomavirus (HPV) in the bloodstream.
Read More